1. Home
  2. LYRA vs AWX Comparison

LYRA vs AWX Comparison

Compare LYRA & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • AWX
  • Stock Information
  • Founded
  • LYRA 2005
  • AWX 1998
  • Country
  • LYRA United States
  • AWX United States
  • Employees
  • LYRA N/A
  • AWX N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • AWX Environmental Services
  • Sector
  • LYRA Health Care
  • AWX Utilities
  • Exchange
  • LYRA Nasdaq
  • AWX Nasdaq
  • Market Cap
  • LYRA 11.0M
  • AWX 12.7M
  • IPO Year
  • LYRA 2020
  • AWX 1998
  • Fundamental
  • Price
  • LYRA $0.17
  • AWX $3.17
  • Analyst Decision
  • LYRA Buy
  • AWX
  • Analyst Count
  • LYRA 5
  • AWX 0
  • Target Price
  • LYRA $4.50
  • AWX N/A
  • AVG Volume (30 Days)
  • LYRA 1.7M
  • AWX 10.4K
  • Earning Date
  • LYRA 11-12-2024
  • AWX 11-08-2024
  • Dividend Yield
  • LYRA N/A
  • AWX N/A
  • EPS Growth
  • LYRA N/A
  • AWX N/A
  • EPS
  • LYRA N/A
  • AWX 0.25
  • Revenue
  • LYRA $1,471,000.00
  • AWX $83,487,000.00
  • Revenue This Year
  • LYRA N/A
  • AWX N/A
  • Revenue Next Year
  • LYRA N/A
  • AWX N/A
  • P/E Ratio
  • LYRA N/A
  • AWX $12.60
  • Revenue Growth
  • LYRA 3.37
  • AWX N/A
  • 52 Week Low
  • LYRA $0.16
  • AWX $2.00
  • 52 Week High
  • LYRA $6.79
  • AWX $3.38
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 36.11
  • AWX 51.06
  • Support Level
  • LYRA $0.19
  • AWX $3.20
  • Resistance Level
  • LYRA $0.21
  • AWX $3.31
  • Average True Range (ATR)
  • LYRA 0.02
  • AWX 0.11
  • MACD
  • LYRA -0.00
  • AWX -0.03
  • Stochastic Oscillator
  • LYRA 6.42
  • AWX 37.50

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: